Astria Therapeutics, Inc. - Common Stock, $0.001 par value per share (ATXS)

Historical Holders from Q3 2021 to Q1 2025

Symbol
ATXS on Nasdaq
CUSIP
04635X102
Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
55.8M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
58.6M
Holdings value
$524M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
108
Number of buys
57
Number of sells
-41
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Astria Therapeutics, Inc. - Common Stock, $0.001 par value per share (ATXS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 13.9% $41.8M 7.82M FMR LLC Dec 31, 2024
Fairmount Funds Management LLC 9.9% $31.3M 5.87M Fairmount Funds Management LLC Dec 31, 2024
ForGrowth III PA B.V. 5.1% $15.3M 2.87M ForGrowth III PA B.V. Dec 30, 2024
Venrock Healthcare Capital Partners III, L.P. 4.4% $13.1M 2.46M Venrock Healthcare Capital Partners III, L.P. Dec 31, 2024
INTEGRATED CORE STRATEGIES (US) LLC 3.5% $10.7M 1.99M Millennium Management LLC Dec 31, 2024

Institutional Holders of Astria Therapeutics, Inc. - Common Stock, $0.001 par value per share (ATXS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 84.3K $450K +$507 $5.34 6
2024 Q4 58.6M $524M +$15.6M $8.94 108
2024 Q3 56.5M $622M +$12.4M $11.01 102
2024 Q2 55.6M $506M -$43M $9.10 100
2024 Q1 55.1M $775M +$330M $14.08 93
2023 Q4 36M $276M +$87.4M $7.68 77
2023 Q3 23M $171M -$12.4M $7.46 68
2023 Q2 24.6M $205M +$5.96M $8.33 75
2023 Q1 23.4M $312M +$19.6M $13.30 66
2022 Q4 21.8M $325M +$180M $14.89 59
2022 Q3 9.83M $88.8M +$41.6M $9.04 40
2022 Q2 5.73M $17.2M -$3.74M $3.00 27
2022 Q1 6.21M $41.7M +$890K $6.71 30
2021 Q4 6.09M $32.8M -$7.41M $5.39 30
2021 Q3 7.21M $63.8M +$63.8M $8.84 35